2023年11月15日 · The 47th GACVS meeting, held virtually on 15–17 May 2024, brought together global experts to address a range of issues in vaccine safety. 13–15 November 2023 meeting - Full report The 3-day hybrid meeting of ACSoMP and GACVS, included topics specific to vaccines safety, pharmacovigilance issues common to both vaccines and medicines, and ...

The Global Advisory Committee on Vaccine Safety (GACVS) provides independent, authoritative, scientific advice to WHO on vaccine safety issues of global or regional concern with the potential to affect in the short or long term national immunization programmes.

2017年7月14日 · GACVS evaluates information from multiple sources to assess vaccine safety. Standardizing, where possible in order to facilitate the assessment process and increase efficiency, was one of the recommendations of the recent 15-year review of GACVS. 29 The Committee has developed guidelines and a presentation template for reviewing the safety profile of new vaccines.

On 13 and 20 July 2021, the COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety (GACVS) met virtually to discuss rare reports of Guillain-Barré Syndrome (GBS) following vaccination with the Janssen and AstraZeneca COVID-19 vaccines. Both vaccines use an adenovirus platform as their backbone.GBS is a rare immune system disorder that results in muscle weakness, pain or ...

2023年9月5日 · The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 as an independent expert advisory body to WHO on policies and issues related to the safety of vaccines. The 46th GACVS meeting held virtually from 15–16 May 2023, brought together global experts to address a range of issues in vaccine safety. A summary of the presentations and recommendations are provided below ...

2024年3月26日 · After careful consideration of all applications submitted to WHO, the following individuals are proposed for membership of the WHO Global Advisory Committee on Vaccine Safety (GACVS).Following a public call for experts, the World Health Organization (WHO) today announced proposed members of the WHO Global Advisory Committee on Vaccine Safety (GACVS). The GACVS will provides independent ...

全球疫苗安全咨询委员会2019冠状病毒病小组委员会于2021年3月16日和19日召开虚拟会议，审查了有关接种阿斯利康covid-19疫苗后出现血栓和血小板减少症的现有信息和数据。

2021年1月22日 · The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 by WHO to respond promptly, efficiently, independently (of WHO), and with scientific rigor to vaccine safety issues of potential global importance. The Committee meets twice a year on a regular basis. Contents of this report include: Global Advisory Committee on Vaccine Safety, 1-3 December 2020

2021年3月19日 · The GACVS COVID-19 subcommittee will continue to review the safety data from all COVID-19 vaccines and update any advice as necessary. The WHO COVID-19 vaccine safety surveillance manual provides guidance to countries on the safety monitoring and adverse events data sharing for the new COVID-19 vaccines, and can be accessed here .

2024年8月21日 · The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999 as an independent expert advisory body to WHO on policies and issues related to the safety of vaccines. The 47th GACVS meeting, held virtually on 15–17 May 2024, brought together global experts to address a range of issues in vaccine safety. The aims of the meeting were to provide updates and solicit feedback ...